For radiotherapy MAASTRO is one of the leaders in biological and translational research, both nationally as internationally. Research successes in the lab or physics are translated to the clinic and are often applied here in clinical trials for the first time world wide. This enables MAASTRO to improve the concept of individualized radiotherapy. Decision support systems developed by the research department of Knowledge Engineering help physicians to choose the best treatment for each single patient.
KWF-onderzoeker van de week: Marc Vooijs
Kanker bestrijden met cholesterolverlagers? Marc Vooijs onderzoekt of deze veelgebruikte medicijnen in staat zijn om glioblastomen (agressieve hersentumoren) gevoeliger te maken voor bestraling.